Neurotrope (NTRP) ROE US GAAP (year values)

FY2022 FY2023 FY2024 FY2025 FY2026   LTM ? CAGR 5 years ?
ROE, % ? -57.4% -99.2% 0.00% -137.4% -276.2%   -242.7%  
Changes by years, y/y, % +43pp -42pp +99pp -139pp     +22.4%

Neurotrope. ROE, %

Neurotrope. ROE, changes, pp

Neurotrope (NTRP) ROE US GAAP (quarter values)

FY2025Q4 FY2026Q1 FY2026Q2 FY2026Q3 FY2026Q4   LTM ?
ROE, % ? -137.4% -188.9% -233.5% -242.7% -276.2%   -242.7%
Changes by years, y/y, % +164pp -958pp -139pp    
Changes by quarters, q/q, % -852pp -51pp -45pp -9pp -34pp    

Neurotrope. ROE, %

Neurotrope. ROE, changes, pp

Neurotrope. ROE, changes, pp